SUMMARY OF PURPOSE / MAJOR RESPONSIBILITIES

岗位目标 / 主要职责概述

• Lead launch excellence (LEx) planning and execution for new vaccine products, ensuring successful market entry, accelerated commercial ramp-up, and optimized product performance through the full launch phase

  主导新疫苗产品的上市卓越（LEx）规划与执行，确保产品成功进入市场，加速商业化进程，并在整个上市阶段优化产品表现

• Coordinate cross-functional new vaccine project planning and portfolio assessment for the China market, providing full business proposals to support management decision-making

  协调跨部门新疫苗项目规划及产品组合评估，为管理层决策提供完整的商业计划书

• Maintain and coordinate the 10-year CSP (Country Strategy Plan) exercise for the vaccine portfolio, consolidating external environment impacts and supporting long-range business planning

  维护并协调疫苗产品组合的10年CSP工作，整合外部环境影响，支持长期业务规划

• Collect and analyze market intelligence — including competitive landscape, policy changes, and pipeline developments — to generate actionable business insights and support strategic decision-making

  收集并分析市场情报，包括竞争格局、政策变化及产品管线动态，形成可落地的商业洞察，支持战略决策

---

KEY ACCOUNTABILITIES

关键职责

---

1. New Vaccine Launch Excellence (LEx) Planning & Execution: 40%

新疫苗上市卓越规划与执行：40%

• Lead and coordinate cross-functional LEx planning for new vaccine products, establishing clear launch readiness milestones, accountability frameworks, and timelines across all relevant functions (Medical, Regulatory, Commercial, Supply, Market Access, etc.)

  主导并协调跨部门新疫苗产品LEx规划，建立清晰的上市准备里程碑、责任框架及时间节点，覆盖医学、注册、商业、供应链、市场准入等所有相关职能部门

• Develop and drive go-to-market strategy and launch roadmap for new vaccine products, including target customer segmentation, channel strategy, pricing and access strategy, and pre-launch activation plans

  制定并推动新疫苗产品的市场进入策略和上市路线图，包括目标客户细分、渠道策略、定价与准入策略及上市前激活计划

• Monitor and evaluate launch performance post-launch against pre-defined KPIs; identify gaps and propose corrective actions to minimize time to peak sales and maximize commercial outcomes

  监测并评估上市后的产品表现，对照预设KPI识别差距，提出纠偏措施，以缩短达峰时间并最大化商业成果

• Facilitate alignment between global and China teams on launch strategy, ensuring global pipeline opportunities and launch standards are appropriately adapted to China market needs and regulatory context

  促进全球与中国团队在上市策略上的对齐，确保全球产品管线机会和上市标准能够适配中国市场需求和监管环境

• Provide full business proposals for new vaccine products, including potential assessment, commercial strategy, sales forecast, and risk analysis, to support management decision-making and cross-functional endorsement

  为新疫苗产品提供完整的商业计划书，包括潜力评估、商业策略、销售预测及风险分析，支持管理层决策及跨部门认可

• Support the achievement of mid-to-long term financial objectives through robust launch planning and disciplined execution tracking

  通过严谨的上市规划和规范的执行跟踪，支持公司中长期财务目标的实现

---

2. 10-Year CSP Exercise Maintenance and Coordination: 30%

年度CSP维护和协调：30%

• Prepare documents and data needed for running the CSP vaccine 10-year forecast

  准备CSP疫苗产品10年预测所需的文件和数据

• Conduct China competitive vaccine products analysis and sales forecast

  分析和预测中国疫苗市场竞争性产品销售数据

• Maintain and update CSP database; provide support for CSP process management

  维护和更新CSP数据库；为CSP流程管理提供支持

• Assist and support in business review deck preparation

  支持并协助业务回顾文件准备

---

3. Market Intelligence Collection & Analytics: 20%

市场竞争情报搜集及分析：20%

• Collect and analyze market intelligence data, competition challenges, local manufacturers' competency and capacity, possible policy changes and their impact; translate findings into business insights, proposals, and suggested action plans

  收集并分析市场情报数据、竞争挑战情况、本土生产商能力与产能、潜在政策变动及其影响，并将其转化为商业洞察、计划书及建议行动方案

• Provide regular summary reports and insights to support identification of business needs, opportunities, and market trends

  定期提供总结报告和分析，支持识别业务需求、市场机遇和市场趋势

---

4. New asset opportunity assessment: 10%

新项目探索与跨部门协作：10%

• Facilitate the evaluation of new vaccine opportunities for China, including potential assessment, business strategy, and sales forecast

  协助评估新疫苗产品管线针对中国市场的机会，包括潜力评估、商业策略及销售预测

• Conduct analysis and insight collection during opportunity assessment; facilitate cross-functional alignment and endorsement both globally and locally

  在机会评估过程中开展分析和信息搜集；促进全球和本地跨部门的对齐与认可

---

REQUIREMENTS

任职要求

Education / 教育背景

• Minimum bachelor's degree in medicine, pharmacy, biology, or related fields; MBA preferred

  医学、药学及生物学相关专业学士及以上学历，工商管理硕士优先

---

Experience & Knowledge / 经验与知识

• At least 8–10 years of experience in the pharmaceutical or vaccine industry, with a strong background in marketing, market strategy, or new product planning

  至少8–10年制药或疫苗行业经验，具有市场营销、市场战略或新产品规划背景

• Proven track record of leading or significantly contributing to at least 2 successful vaccine or biologics product launches in China

  具有在中国主导或深度参与至少2个疫苗或生物制品成功上市的经验

• Hands-on experience in launch excellence (LEx) planning, launch readiness assessment, and go-to-market execution for pharmaceutical or vaccine products

  具有疫苗或药品上市卓越（LEx）规划、上市准备评估及市场进入执行的实操经验

• Familiar with existing medical and biological products regulations and policies in China

  熟悉中国现行医学和生物制品法规和政策

• Deep knowledge of vaccine products and China/global market landscape

  深入了解疫苗产品及国内外市场格局

---

Core Competencies / 核心能力素质

• Strategic thinking with strong analytical skills and business acumen; ability to translate complex data into clear, actionable recommendations

  战略思维，具备强大的分析能力和商业洞察力；能够将复杂数据转化为清晰、可落地的建议

• Demonstrated ability to lead cross-functional teams through complex, multi-stakeholder launch processes with accountability and discipline

  具备带领跨部门团队完成复杂、多方利益相关者上市流程的能力，具有责任心和执行纪律性

• Excellent project management skills with ability to manage multiple priorities simultaneously and deliver results under tight timelines

  出色的项目管理能力，能够同时处理多项优先事项，并在紧迫时间节点内交付成果

• Strong communication and presentation skills; able to influence and align senior stakeholders across functions and geographies

  出色的沟通和汇报能力，能够影响并对齐跨职能、跨地区的高层决策者

• Maturity and initiative, with both team spirit and independent working capability

  成熟、主动性强，既有团队合作精神又能独立完成任务

• Ability to travel domestically and internationally as required

  能够根据业务需求进行国内外差旅

• Fluent in both English and Mandarin

  中英文流利

Pursue progress, discover extraordinary

Better is out there. Better medications, better outcomes, better science. But progress doesn’t happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let’s be those people.

At Sanofi, we provide equal opportunities to all regardless of race, colour, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, ability or gender identity.

Watch our ALL IN video and check out our Diversity Equity and Inclusion actions at sanofi.com!